MELBOURNE, Australia and SAN FRANCISCO, March 02, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...

LITTLE RIVER, S.C. (WBTW) — A boat in Little River sustained heavy fire damage Wednesday morning, while causing damage to two nearby boats, Horry County Fire Rescue said. Crews responded just after ...

GM recalls thousands of vehicles over transmission issue that could increase risk of crash Women attacked factory over Gaza - prosecutors Latest update on blizzard of 2026 as parts of Massachusetts ...

It's well known that spaceflight causes muscle atrophy and other biological changes in reduced gravity, and especially in ...

Please provide your email address to receive an email when new articles are posted on . WAIKOLOA, Hawaii — In this expert perspective from Retina 2026, Michael S. Ip, MD, discusses a real-world study ...

An experimental drug that Theravance Biopharma touted as a potential first-in-class medicine for multiple system atrophy has failed a Phase 3 study, triggering a corporate shakeup that ends this ...

Alterity outlines three priorities for 2026 following successful completion in 2025 of Phase II trial of ATH434 in Multiple System Atrophy Company preparing for end-of-phase II meeting with the US ...

Multiple sclerosis (MS) is a chronic, often debilitating autoimmune disease that affects the central nervous system (CNS). This disease causes the immune system to mistakenly attack the protective ...

President Donald Trump is coming under increasing pressure to explain his military campaign in Iran to the American people. So far, the president has not delivered a prime-time address or held a press ...